Malaria vaccines:where are we and where are we going?
- 1 December 2002
- journal article
- review article
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 2 (12) , 737-743
- https://doi.org/10.1016/s1473-3099(02)00451-6
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Genome sequence and comparative analysis of the model rodent malaria parasite Plasmodium yoelii yoeliiNature, 2002
- Naturally Exposed Populations Differ in Their T1 and T2 Responses to the Circumsporozoite Protein ofPlasmodium falciparumInfection and Immunity, 2002
- The pathogenic basis of malariaNature, 2002
- Current Status of Malaria and Potential for ControlClinical Microbiology Reviews, 2001
- Recombinant Human Antibodies Specific for the Pfs48/45 Protein of the Malaria Parasite Plasmodium falciparumPublished by Elsevier ,2001
- Differential ability of specific regions of Plasmodium falciparum sexual‐stage antigen, Pfs230, to induce malaria transmission‐blocking immunityParasite Immunology, 2000
- Immunogenicity of Ty-VLP bearing a CD8+ T cell epitope of the CS protein of P. yoelii: enhanced memory response by boosting with recombinant vaccinia virusVaccine, 2000
- Immune effector mechanisms in malariaCurrent Opinion in Immunology, 1999
- Host Age as a determinant of naturally acquired immunity to Plasmodium falciparumParasitology Today, 1995
- The Role of T H 1 and T H 2 Cells in a Rodent Malaria InfectionScience, 1993